SLC2A2, solute carrier family 2 member 2, 6514

N. diseases: 123; N. variants: 32
Disease: Liver carcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma 		0.330 AlteredExpression disease BEFREE GLUT2 protein expression was significantly reduced in human HCC as compared to normal liver tissue and its expression in HCC was inversely associated to malignancy (p < 0.001). 31407220 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma 		0.330 Biomarker disease BEFREE Taken together, SLC2A2 was associated with clinical stages and independently associated with overall survival in patients with HCC. 28978124 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma 		0.330 AlteredExpression disease BEFREE GLUT2 was detected in 31% of the samples, being mainly expressed in breast, colon, and liver carcinoma. 16523487 2006
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma 		0.330 Biomarker disease CTD_human The liver type glucose transporter GLUT 2 was decreased in all adenomas and hepatocellular carcinomas (HCC). 8364915 1993